David Pyrce
Amministratore Delegato presso Devacell, Inc.
Profilo
David Pyrce currently works at Devacell, Inc., as Chief Executive Officer from 2020 and Cognigenics, Inc., as Chief Executive Officer from 2024.
Mr. Pyrce also formerly worked at Nexsun Corp., as Chief Executive Officer, Canton Corp., as Chief Executive Officer, NantKwest, Inc., as Chief Commercial Officer & Senior VP-Innovation from 2015 to 2020, and OmeCare Ventures, Inc., as Chief Business Officer.
Mr. Pyrce received his Masters Business Admin degree from Illinois Institute of Technology and undergraduate degree from Northern Illinois University.
Posizioni attive di David Pyrce
| Società | Posizione | Inizio |
|---|---|---|
Devacell, Inc.
 Devacell, Inc. Pharmaceuticals: MajorHealth Technology Devacell, Inc. provides a novel enzyme nano-encapsulation technology intended to deliver a sufficient viral dose to metastases. The company was founded by Inanc Ortac and is headquartered in San Diego, CA. | Amministratore Delegato | 29/10/2020 |
Cognigenics, Inc.
 Cognigenics, Inc. Miscellaneous Commercial ServicesCommercial Services Cognigenics, Inc. is a company founded in 2019 that specializes in genetic neuroengineering using patent-pending CRISPR technology to target and modulate neural circuits responsible for mental health disorders such as anxiety, depression, ADHD, and cognitive impairment. The company is based in Eagle, ID. Cognigenics is revolutionizing the treatment of mental health conditions through their innovative technology. The company was founded by John L. Mee, Dean Radin, and Barry J. Linder, with John L. Mee serving as CEO since incorporation. | Amministratore Delegato | 13/01/2024 |
Precedenti posizioni note di David Pyrce
| Società | Posizione | Fine |
|---|---|---|
| IMMUNITYBIO, INC. | Contatto Relazioni con gli Investitori | 01/09/2020 |
| Nexsun Corp. | Presidente | - |
| Canton Corp. | Presidente | - |
OmeCare Ventures, Inc.
 OmeCare Ventures, Inc. Miscellaneous Commercial ServicesCommercial Services OmeCare Ventures, Inc. engages in health and wellness industry. It provides fitness, nutrition, skin, mental health DNA insight, pain medication DNA insight, carrier status DNA insight and cannabis DNA products. The company was founded in September 2008 by James Plante and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Formazione di David Pyrce
| Illinois Institute of Technology | Masters Business Admin |
| Northern Illinois University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
NantKwest, Inc.
 NantKwest, Inc. BiotechnologyHealth Technology NantKwest, Inc. engages in the research and development of immunotherapies. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The company was founded by Gary N. Keller and Hans Georg Klingemannon October 7, 2002 and is headquartered in San Diego, CA. | Health Technology |
OmeCare Ventures, Inc.
OmeCare Ventures, Inc. Miscellaneous Commercial ServicesCommercial Services OmeCare Ventures, Inc. engages in health and wellness industry. It provides fitness, nutrition, skin, mental health DNA insight, pain medication DNA insight, carrier status DNA insight and cannabis DNA products. The company was founded in September 2008 by James Plante and is headquartered in San Diego, CA. | Commercial Services |
| Nexsun Corp. | |
| Canton Corp. | |
Devacell, Inc.
Devacell, Inc. Pharmaceuticals: MajorHealth Technology Devacell, Inc. provides a novel enzyme nano-encapsulation technology intended to deliver a sufficient viral dose to metastases. The company was founded by Inanc Ortac and is headquartered in San Diego, CA. | Health Technology |
Cognigenics, Inc.
Cognigenics, Inc. Miscellaneous Commercial ServicesCommercial Services Cognigenics, Inc. is a company founded in 2019 that specializes in genetic neuroengineering using patent-pending CRISPR technology to target and modulate neural circuits responsible for mental health disorders such as anxiety, depression, ADHD, and cognitive impairment. The company is based in Eagle, ID. Cognigenics is revolutionizing the treatment of mental health conditions through their innovative technology. The company was founded by John L. Mee, Dean Radin, and Barry J. Linder, with John L. Mee serving as CEO since incorporation. | Commercial Services |
- Borsa valori
- Insiders
- David Pyrce
